These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5071537)

  • 1. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
    Stein L; Wise CD
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():298-314. PubMed ID: 5071537
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-Hydroxydopamine, noradrenergic reward, and schizophrenia.
    Science; 1972 Feb; 175(4024):919-23. PubMed ID: 5008611
    [No Abstract]   [Full Text] [Related]  

  • 3. Norepinephrine reward pathways: role of self-stimulation, memory consolidation, and schizophrenia.
    Stein L
    Nebr Symp Motiv; 1975; 22():113-59. PubMed ID: 1688
    [No Abstract]   [Full Text] [Related]  

  • 4. Self-stimulation reward pathways: norepinephrine vs dopamine.
    Stein L; Belluzzi JD; Ritter S; Wise CD
    J Psychiatr Res; 1974; 11():115-24. PubMed ID: 4461783
    [No Abstract]   [Full Text] [Related]  

  • 5. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stein and Wise's neurochemical model of schizophrenia].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):127-34. PubMed ID: 842218
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of antibodies to dopamine-beta-monooxygenase on the level of catecholamines in the brain].
    Pogosian AS; Boiadzhian AS; Karagezian KG; Aĭvazian VA; Movsesian AV
    Biull Eksp Biol Med; 1991 Aug; 112(8):133-4. PubMed ID: 1786369
    [No Abstract]   [Full Text] [Related]  

  • 8. Some central adrenergic mechanisms connected with the animals ability to form instrumental conditioned reflexes.
    Krause M; Gwòzdz B
    Acta Physiol Pol; 1973; 24(1):93-5. PubMed ID: 4716351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenia and neurotransmitters].
    Nagatsu T; Fujita K; Kawai K; Shinpo K; Shinzato M
    Nihon Rinsho; 1984 Apr; 42(4):891-901. PubMed ID: 6384571
    [No Abstract]   [Full Text] [Related]  

  • 11. Stein and Wise theory of schizophrenia: a possible mechanism for 6-hydroxydopamine formation in vivo.
    Adams RN
    Behav Biol; 1972 Dec; 7(6):861-6. PubMed ID: 4655404
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats.
    Phillips AG; Fibiger HC
    Behav Biol; 1976 Feb; 16(2):127-43. PubMed ID: 1259675
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of the 6-hydroxydopamine theory of schizophrenia.
    Adams RN
    Bull Menninger Clin; 1974 Jan; 38(1):57-69. PubMed ID: 4811367
    [No Abstract]   [Full Text] [Related]  

  • 14. Self-stimulation in the mesencephalic trajectory of the ventral noradrenergic bundle.
    Ritter S; Stein L
    Brain Res; 1974 Nov; 81(1):145-57. PubMed ID: 4611589
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 17. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 18. Rewarding properties of the stereoisomers of 4-methylaminorex: involvement of the dopamine system.
    Meririnne E; Kajos M; Kankaanpää A; Koistinen M; Kiianmaa K; Seppälä T
    Pharmacol Biochem Behav; 2005 Aug; 81(4):715-24. PubMed ID: 15982727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine.
    Stein L; Wise CD
    Science; 1971 Mar; 171(3975):1032-6. PubMed ID: 5100789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemistry of reward and punishment: some implications for the etiology of schizophrenia.
    Stein L
    J Psychiatr Res; 1971 Aug; 8(3):345-61. PubMed ID: 4939380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.